Human T-cell leukemia virus type 1 Tax protein (Tax)

The Human T-cell leukemia virus type 1 (HTLV-1) Tax protein is a 40-kDa viral oncoprotein and trans-activator that is essential for viral replication and the transformation of infected T-cells (UniProt P14079). It primarily functions by activating the viral 5' long terminal repeat (LTR) through the recruitment of host transcription factors such as CREB and p300 (PubMed: 8970957). Beyond its role in the viral life cycle, Tax hijacks multiple cellular signaling pathways, most notably the NF-kappaB pathway, to promote uncontrolled cell proliferation and inhibit apoptosis (NIH: PMC12660582). These activities are central to the development of Adult T-cell leukemia/lymphoma (ATL) and the neurodegenerative disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (PubMed: 22789739). While no drugs specifically targeting Tax are currently approved, the combination of arsenic trioxide and interferon-alpha is known to induce its proteasomal degradation in ATL cells (Nature Communications, 2024). Tax is also a major target for the host's cytotoxic T-lymphocyte response, making it a key focus for immunotherapy and vaccine development (NIH: PMC12660582). Recent research has identified host kinases like KDR (VEGFR2) as potential indirect targets, as their inhibition leads to Tax degradation and cell death in HTLV-1-infected cells (Nature Communications, 2024).

Other names

Protein Tax-1HTLV-1 trans-activator proteinProtein X-LORProtein PX

Induction of proteasomal degradation of the Tax protein and inhibition of Tax-mediated transactivation of viral and cellular genes.